PrimeRFP SCOUT · Federal Contract Profile

Ino Therapeutics (XXQHL619FUN6)Federal contracts · 6 recompetes

Ino Therapeutics holds $2.5M in federal volume across 84 award actions, with 76% at Department of Defense (DOD). SCOUT tracks 6 incumbent recompetes — an estimated $1.3M returning to market over the next 24 months (High exposure). Primary work: Pharmaceutical Preparation (100% prime). Obligations are down 64% year over year.

$2.5M
Federal Volume
6
Recompetes (24mo)
DOD
Top Agency · 76% firm-wide
84
Award Actions

Choose one — this changes what we ask next

Score my firm against Ino Therapeutics

Email me when a Ino Therapeutics recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026

Why are you looking at Ino Therapeutics?

Score my firm against Ino Therapeutics

Email me when a Ino Therapeutics recompete window opens.

What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC Q517 PHARMACY SERVICES

Where they win

2 agencies
% of firm-wide obligated ($2.5M) · all agencies

Recompete exposure: High · 6 in 24mo

Ino Therapeutics has an estimated $1.3M in contracts returning to market over the next 24 months.

With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…
Peter Lierni, Solutioneering
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Ino Therapeutics hold?

Ino Therapeutics (UEI XXQHL619FUN6) shows $2.5M across 84 award actions in SCOUT’s public USASpending-backed profile, with Department of Defense (DOD) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Ino Therapeutics have?

Ino Therapeutics shows $2.5M across 84 award actions. SCOUT tracks 6 incumbent recompetes ($1.3M) returning to market in the next 24 months.

Which agencies does Ino Therapeutics work with?

Ino Therapeutics’s firm-wide obligated mix is led by Department of Defense (DOD) (76%), Department of Veterans Affairs (VA) (26%).

What is the UEI for Ino Therapeutics?

The Unique Entity ID (UEI) for Ino Therapeutics is XXQHL619FUN6.

Does Ino Therapeutics have contracts coming up for recompete?

Yes — SCOUT tracks 6 incumbent recompetes in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/ino-therapeutics-llc